Rhythm Technologies, Inc. targets $880M in 2026 revenue with 12.5% EBITDA margins and primary care growth. Find out why IRTC stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results